<h2><strong>CORONAVIRUS (COVID-19)</strong></h2>
<p>{notice;fontweight=500:<strong><em>For information and helpful resources on Monkeypox, click </em></strong><a href="https://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-Healthcare/Vaccine-Preventable-Diseases/Monkeypox" target="_blank"><em>here</em></a><strong><em>. To view Frequently Asked Questions (FAQs) on Monkeypox prevention, symptoms, treatment, and more, click </em></strong><a href="https://www.health.mil/Reference-Center/Frequently-Asked-Questions/Monkeypox-FAQ" target="_blank"><em>here</em></a><strong><em>.}</em></strong></p>
<p>Timely COVID-19 updates for TOP Providers can be found below. For COVID-19 resources for TOP Providers, click <a href="https://tricare-overseas.com/providers/resources/covid-19-information-for-top-providers/provider-resources" target="_blank">here</a>.</p>
<p>For COVID-19 information for TOP beneficiaries, click <a href="https://tricare-overseas.com/beneficiaries/resources/COVID-19" target="_blank">here</a>.</p>
<h4 style="text-align: center;"><strong>COVID-19 Updates for TOP Providers:</strong></h4>
<h4>Administration of Third Dose COVID-19 Vaccine Approved</h4>
<p>International SOS would like to inform you of recent changes to the TRICARE Policy Manual, specifically addressing the effective date of coverage for immunizations, particularly COVID-19. The change allows reimbursement for the administration of a third dose of COVID-19 vaccines. The CDC has published an interim recommendation on their website (<a href="http://www.cdc.gov/" target="_blank"><strong>http://www.cdc.gov</strong></a>) which will align with the effective date of coverage. Please visit the website for more details.</p>
<h4>Temporary Coverage of Investigational Drugs for Treatment of COVID-19</h4>
<p>In response to the COVID-19 pandemic, the Defense Health Agency (DHA) has temporarily covered treatment use of investigational drugs under expanded access when for the treatment of COVID-19 and its associated sequelae. This change permits coverage of the investigational drug itself (i.e., the drug itself will now be able to be cost-shared), when for the treatment of COVID-19 or its associated sequelae, in settings approved by the U.S. Food and Drug Administration (FDA) under expanded access (coverage in clinical trial settings continues to be excluded). This coverage will be applied by International SOS in overseas locations for drugs without formal marketing approval when International SOS determines that such usage meets criteria substantially similar to FDA requirements for treatment use of investigational new drugs under this criteria. This change is no longer applicable upon expiration of the President’s declared national emergency for the COVID-19 pandemic. For treatment use of investigational drugs provided by any overseas provider, these provisions are effective March 10, 2020, and will expire upon conclusion of the COVID-19 pandemic, as determined by the Assistant Secretary of Defense for Health Affairs.</p>
<h4>Temporary Coverage of NIAID-Sponsored Clinical Trials for the Treatment or Prevention of COVID-19</h4>
<p>Effective October 30, 2020, TRICARE regulations were temporarily changed to add coverage of clinical trials for the treatment or prevention of COVID-19 or its associated sequelae, if the U.S. National Institute of Allergy and Infectious Disease (NIAID) is either the trial sponsor or trial collaborator. Coverage for COVID-19 clinical trials will last through the end of the President’s declared national emergency for the COVID-19 pandemic. Click <a href="https://tricare-overseas.com/beneficiaries/resources/COVID-19/NIAID-Sponsored-Clinical-Trials" target="_blank">here</a> to learn more.</p>
<h4>Provider Operating Hours</h4>
<p>International SOS understands that Providers may need to close their practice or adjust their services and/or operating hours due to the ongoing Coronavirus (COVID-19) pandemic. We also understand that circumstances and guidelines may change rapidly and often with short notice. If there will be a critical change in your operations, please notify International SOS as soon as possible by <a href="https://tricare-overseas.com/contact-us" target="_blank">contacting</a> your TOP Regional Call Center (listen carefully to the prompts for the best option to serve you) to speak with a member of the TOP Provider Support Services (TPSS) team.</p>